2012 Drugs that promote or inhibit coagulation
Overview
|
Therapeutic Strategies
|
Thrombolytics
|
Anticoagulants
|
Antiplatelet drugs
|
Coagulants
Anticoagulants
/
DTIs
/ Pharmacokinetics
Direct thrombin inhibitors :
ARGATROBAN
,
BIVALI
RUDIN
, DABIGATRAN, HI
RUDIN
, LEPI
RUDIN
Pharmacokinetics
given
IV
"
RUDIN
s" and
DABIGATRAN
are excreted by kidney
ARGATROBAN
metabolized by liver
monitored
(if necessary)
by
aPTT
ARGATROBAN
causes elevated
INR
s because of
test interference
, making the transition to
WARFARIN
difficult
search
Mechanisms of action
Indirect thrombin inhibitors
ATIII Activators
Mechanism of action
Pharmacokinetics
LMW Heparins
Therapeutic uses
Adverse effects
Protamine sulfate
Factor Xa inhibitors
DTIs
Mechanism of action
Pharmacokinetics
Therapeutic uses
Adverse effects
Zymogen synthesis inhibitor
Mechanism of action
Pharmacokinetics
Therapeutic uses
Adverse effects
Interactions
Increased actions
Decreased actions
Drug interaction theory
Specific drug interactions
Phytonadione
Email: Dr. Janet Fitzakerley
| ©2012 University of Minnesota Medical School Duluth | Last modified: 31-may-12 7:25 PM